Buy Voyager Therapeutics Stock | VYGR Stock Price & Latest News | Public
VYGR

Voyager Therapeutics

$0.00 (0.00%)Today

    About VYGR

    Voyager Therapeutics, Inc. operates as a clinical-stage gene therapy company, which develops treatments for patients suffering from central nervous system. Its pipeline of gene therapy programs includes VY-AADC, VY-SOD101, VY-HTT01, VY-FXN01, Tau Program, and VY-NAV01. ...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.22
    -0.44
    -0.66
    Q4 2019
    Q1 2020
    Q2 2020
    Q3 2020

    Expected EPS
    Q3 2020

    -$0.37

    Actual EPS
    Q3 2020

    Stats

    Market Cap$414,54M
    Volume4,74k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$17.14
    1 Year Low$6.26
    Open$11.13
    High$11.13
    Low$10.53

    Buy any stock with any amount of money.

    Download the App
    Download the app